The reality is we are all guessing here (me included). There’s no harm in that, and it’s certainly entertaining, but I sense there may be a significant gap between the likely outcome and the expectations of some posters on this forum.
What we’ve observed so far (small share purchase, $1m premium in exchange for exclusivity period) doesn’t align to what I would expect from a large Pharma. This doesn’t mean NEU isn’t getting the best deal, just that the partner does not need to be a large Pharma in order for NEU to extract full value.
I expect the best way to achieve maximum value for NEU and it’s shareholders is to structure a deal with a smaller upfront payment (sufficient to cover the cost of phase 3) and retain a larger percentage of future revenues. A deal of this nature does not require the copious amounts of capital that some larger Pharma’s currently have available to them, it only requires sufficient cash to fund the necessary phase 3 trials, production set-up, and initial distribution costs. This opens up the field to a number of potential partners at the lower end of the market (US$1b-US$10b market cap).
I’m sure we’re all looking forward to the announcement to find out who the partner is and how the deal is structured. We will then also know which posters are exhibiting irrational exuberance or being unnecessarily pessimistic. I hope my view is realistic, but we’ll soon find out… if I’m wrong I’ll take it on the chin and work out how to improve my analysis for the next time!
.
- Forums
- ASX - By Stock
- Biogen my number 1
The reality is we are all guessing here (me included). There’s...
-
- There are more pages in this discussion • 113 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add NEU (ASX) to my watchlist
(20min delay)
|
|||||
Last
$13.18 |
Change
-0.430(3.16%) |
Mkt cap ! $1.684B |
Open | High | Low | Value | Volume |
$13.64 | $13.67 | $13.18 | $8.868M | 666.8K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 5233 | $13.18 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$13.24 | 1000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 5233 | 13.180 |
1 | 2135 | 13.170 |
2 | 1561 | 13.160 |
1 | 2135 | 13.150 |
3 | 2356 | 13.130 |
Price($) | Vol. | No. |
---|---|---|
13.240 | 1000 | 1 |
13.290 | 3819 | 3 |
13.300 | 2000 | 1 |
13.310 | 2135 | 1 |
13.340 | 2135 | 1 |
Last trade - 16.10pm 09/10/2024 (20 minute delay) ? |
Featured News
NEU (ASX) Chart |
The Watchlist
AHK
ARK MINES LIMITED
Ben Emery, Executive Director
Ben Emery
Executive Director
SPONSORED BY The Market Online